Trials / Completed
CompletedNCT03233360
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,533 (actual)
- Sponsor
- National Cancer Centre, Singapore · Academic / Other
- Sex
- All
- Age
- 21 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The INSIGHT ('Insight into Real-world Practice of Management of HCC in Asia-Pacific') registry is designed as a multi-centre longitudinal cohort study of patients diagnosed with HCC between 1st January 2013 and 31st December 2019 in nine countries (i.e., South Korea, Taiwan, Thailand, Japan, China, Hong Kong, Australia, New Zealand and Singapore). Approximately 30% of the sample size will be identified retrospectively and 70% will be identified prospectively from the start date of the registry (October 2016), with an even distribution of consecutively diagnosed patients within the different years.
Conditions
Timeline
- Start date
- 2017-04-17
- Primary completion
- 2020-06-30
- Completion
- 2020-12-31
- First posted
- 2017-07-28
- Last updated
- 2022-12-05
Locations
34 sites across 9 countries: Australia, China, Hong Kong, Japan, New Zealand, Singapore, South Korea, Taiwan, Thailand
Source: ClinicalTrials.gov record NCT03233360. Inclusion in this directory is not an endorsement.